Interestingly, DSCAM-AS1 knockdown could mimic the effect of progesterone by inhibiting breast cancer cell migration and invasion comparable to the extent obtained following treatment of the PR-positive T47-D and BT474 cells with progesterone (Fig. 2D–G). This evidence concerns the gene PGR and breast carcinoma.